story of the week
Semaglutide in Patients With Obesity-Related Heart Failure and Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
N. Engl. J. Med 2024 Mar 28;390(15)1394-1407, MN Kosiborod, MC Petrie, BA Borlaug, J Butler, MJ Davies, GK Hovingh, DW Kitzman, DV Møller, MB Treppendahl, S Verma, TJ Jensen, K Liisberg, ML Lindegaard, W Abhayaratna, FZ Ahmed, T Ben-Gal, V Chopra, JA Ezekowitz, M Fu, H Ito, M Lelonek, V Melenovský, B Merkely, J Núñez, E Perna, M Schou, M Senni, K Sharma, P van der Meer, D Von Lewinski, D Wolf, SJ ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.